Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

Breast cancer is now the most common cancer worldwide, and it is also the main cause of cancer-related death in women. Survival rates for female breast cancer have significantly improved due to early diagnosis and better treatment. Nevertheless, for patients with advanced or metastatic breast cancer...

Full description

Bibliographic Details
Main Authors:	Jiawei Li, Eyleen L. K. Goh, Ji He, Yan Li, Zhimin Fan, Zhigang Yu, Peng Yuan, Dong-Xu Liu
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Biology
Subjects:	breast cancer targeted therapy therapeutic target metastatic breast cancer immunotherapy chemoimmunotherapy
Online Access:	https://www.mdpi.com/2079-7737/12/5/697

Similar Items

Emerging intrinsic therapeutic targets for metastatic breast cancer
by: Li, Jiawei, et al.
Published: (2023)

Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
by: Beibei Guo, et al.
Published: (2023-07-01)

TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP), A Novel Therapeutic Target Of Breast Cancer
by: Cheng L, et al.
Published: (2019-10-01)

Role of Molecular Targeted Therapeutic Drugs in Treatment of Breast Cancer: A Review Article
by: Himanshu Singh
Published: (2023-06-01)

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer
by: Xueting Li, et al.
Published: (2024-01-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments
by: Ismail Essadi, et al.
Published: (2023-03-01)

ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
by: Xuan Cheng, et al.
Published: (2021-11-01)

Neutrophils as potential therapeutic targets for breast cancer
by: Yi-Ting Gong, et al.
Published: (2023-12-01)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
by: Md Abdus Subhan, et al.
Published: (2023-04-01)

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
by: Laura Morrison, et al.
Published: (2023-07-01)

Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
by: Shuanghe Li, et al.
Published: (2022-10-01)

Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies
by: Guangman Cui, et al.
Published: (2021-07-01)

Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
by: Jossimar Coronel-Hernández, et al.
Published: (2021-10-01)

Oncolytic virotherapy for metastatic breast cancer – a case report
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
by: Mery B, et al.
Published: (2023-04-01)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
by: Adam Barsouk, et al.
Published: (2019-09-01)

Current management options in metastatic renal cell cancer
by: Sittu Govindasamy Dinakaran Gangadaran
Published: (2017-06-01)

Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
by: Brian Effer, et al.
Published: (2023-07-01)

Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer
by: Layal Al Mahmasani, et al.
Published: (2023-10-01)

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
by: Bi Lian, et al.
Published: (2023-03-01)

Recent advances in therapeutic strategies for triple-negative breast cancer
by: Yun Li, et al.
Published: (2022-08-01)

Metastatic breast cancer patient perceptions of somatic tumor genomic testing
by: Elizabeth J. Adams, et al.
Published: (2020-05-01)

Advances in MUC1-Mediated Breast Cancer Immunotherapy
by: Zhifeng Li, et al.
Published: (2022-07-01)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
by: Rhynelle S. Dmello, et al.
Published: (2021-02-01)

Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice
by: Simona Bruzas, et al.
Published: (2021-09-01)

Targeting Breast Cancer: An Overlook on Current Strategies
by: Domenico Iacopetta, et al.
Published: (2023-02-01)

How has the field of metastatic breast cancer in bones evolved over the past 22 years?
by: Yi Chen, et al.
Published: (2023-06-01)

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint
by: Jyoti Bajpai, et al.
Published: (2017-01-01)

Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer
by: Xiaoxiao Chen, et al.
Published: (2022-09-01)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
by: Italia Falcone, et al.
Published: (2020-11-01)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy
by: Hui Liu, et al.
Published: (2020-06-01)

Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression
by: Océane Campion, et al.
Published: (2020-07-01)

Triple negative breast cancer: special histological types and emerging therapeutic methods
by: Lu Cao, et al.
Published: (2020-05-01)

The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling
by: Benjamin Verret, et al.
Published: (2022-08-01)

Therapeutic methods in the treatment of triple-negative breast cancer - a review
by: Karolina Joanna Ziętara, et al.
Published: (2022-07-01)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020-12-01)

Therapeutic challenges in quadruple negative breast cancer
by: Galina Yaneva, et al.
Published: (2023-01-01)

Metastatic breast cancer: Endocrine therapy landscape reshaped
by: Mohamad Adham Salkeni, et al.
Published: (2017-10-01)

Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
by: L Yu Vladimirova
Published: (2016-12-01)